CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

MEDICAMEN BIOTECH LTD.

NSE : MEDICAMEQBSE : 531146ISIN CODE : INE646B01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE536.20-10.1 (-1.85 %)
PREV CLOSE () 546.30
OPEN PRICE () 547.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10276
TODAY'S LOW / HIGH ()528.00 566.50
52 WK LOW / HIGH ()356.75 685.55
NSE536.25-11.6 (-2.12 %)
PREV CLOSE() 547.85
OPEN PRICE () 547.40
BID PRICE (QTY) 536.25 (4)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 83957
TODAY'S LOW / HIGH() 526.10 566.00
52 WK LOW / HIGH ()355.45 689.55
ChairmanRahul Bishnoi
Company SecretaryParul Choudhary
Non Executive DirectorVimal Kumar Shrawat
Ashwani Kumar Sharma
Suresh Kumar Singh
Sanjay Bansal
Non Executive Independent DirectorHarish Pande
Arun Kumar
Ravi Kumar Bansal
Sumita Dwivedi
Sangeeta Bishnoi
Incorporation Year : 1993

Registered Office :

Address : 1506,Chiranjiv Tower,43, Nehru Place New Delhi,
Delhi-110019 .

Phone : 011-47589500-51

Email :  info@medicamen.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX79389.06-553.12 (-0.69%)
NIFTY24205.35-135.50 (-0.56%)
Dow Jones 42141.54-91.51 (-0.22%)
Nasdaq 18607.93-104.82 (-0.56%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI